Does Horizon Blue Cross Blue Shield of New Jersey Cover Ozempic?
The verdict
Conditional on most plans
Horizon BCBS of New Jersey covers Ozempic for type 2 diabetes with prior authorization based on medical necessity criteria. As the dominant commercial insurer in New Jersey and the state's BCBS licensee, Horizon's formulary affects the majority of commercially insured New Jerseyans. Off-label weight-loss use is not covered. Note: Horizon's Wegovy weight-loss coverage (plan-dependent with PA and medical necessity) is a separate coverage pathway — Ozempic for T2D and Wegovy for weight loss are handled under different PA criteria. Formulary details not publicly confirmed at drug level — verify on Horizon drug lookup.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Horizon Blue Cross Blue Shield of New Jersey using your member ID.
Key facts
Horizon BCBS of New Jersey is the state's BCBS licensee and the dominant commercial insurer in New Jersey — a highly regulated insurance market with strong consumer-protection standards for coverage of clinically established medications.
NJ Department of Banking and Insurance market data
Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D adults with known heart disease — it is not FDA-approved for weight loss.
FDA drug labeling, Ozempic (semaglutide injection)
The IRA Maximum Fair Price for semaglutide (Ozempic/Rybelsus/Wegovy) under Medicare is $274 per 30-day supply, effective January 1, 2027.
CMS, IRA Drug Price Negotiation Program, 2024
Medicare vs. commercial coverage
Whether Horizon Blue Cross Blue Shield of New Jersey covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage (Horizon Medicare Blue): Ozempic is covered for type 2 diabetes with prior authorization. The 2026 Part D $2,100 out-of-pocket cap limits annual beneficiary exposure. The IRA Maximum Fair Price for semaglutide is $274 per 30-day supply effective January 1, 2027. Medicare enrollees cannot use the NovoCare savings card (federal anti-kickback rules). Ozempic is not covered for weight loss on any Horizon Medicare plan — off-label weight-loss use is statutorily excluded from Medicare Part D.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: Horizon BCBS of NJ covers Ozempic for type 2 diabetes with prior authorization based on documented medical necessity, including T2D diagnosis and prior oral therapy. As the dominant insurer in New Jersey — a highly regulated insurance market — Horizon's formulary affects most commercially insured NJ residents. Formulary tier and copay are not publicly confirmed at the drug level; verify on Horizon's drug lookup. Not covered for off-label weight loss. Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150/28-day supply); not available to Medicare or Medicaid enrollees. ACA/Individual: covered for T2D with PA; not covered for weight loss. Medicaid (NJ FamilyCare): Horizon manages some NJ FamilyCare (NJ Medicaid) plans; Ozempic is covered for T2D with PA and nominal Medicaid cost-share through NJ FamilyCare. Not covered for off-label weight loss under any NJ FamilyCare plan.
The 2 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 2 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing). NovoCare self-pay: ~$199/month intro (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial/Employer: tier-based cost-share; specific tier and copay not publicly published — verify on Horizon's drug lookup. Medicare Advantage (Horizon Medicare Blue): cost-share per plan design; $2,100 OOP cap 2026; IRA Maximum Fair Price $274/30-day effective January 1, 2027. NJ FamilyCare Medicaid: nominal $0–$4 typical for covered T2D use.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare Advantage, Medicaid, VA, DoD, or TRICARE beneficiaries. Verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Specific tier and cost-share for Horizon BCBS NJ commercial and Medicare plans are not publicly confirmed at the drug level. Verify on Horizon's drug lookup or by calling member services.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Use Horizon's online drug lookup tool to confirm formulary status and PA requirements
Visit horizonblue.com and use the drug-lookup or formulary tool with your member ID to confirm Ozempic's tier, any prior-authorization requirements, and step-therapy criteria for your specific commercial, ACA, or Horizon Medicare Blue plan. Tier and copay are not published at the drug level in public documents.
- 2
Have your prescriber submit the prior authorization for type 2 diabetes
The PA requires documented T2D diagnosis and medical necessity, including evidence of prior oral antidiabetic therapy (or a documented medical reason such therapy cannot be used). The clinical indication must be type 2 diabetes — a weight-management indication will not support PA approval. Note that Horizon's PA criteria for Ozempic (T2D) are separate from its PA criteria for Wegovy (weight loss), which involves additional BMI and prior-attempt documentation.
- 3
Check NovoCare savings card eligibility if you have commercial coverage
If you have a Horizon BCBS NJ commercial or employer-sponsored plan and a confirmed T2D diagnosis, visit NovoCare.com to enroll in the Ozempic Savings Card, which may reduce your out-of-pocket cost to as little as $25 per fill (max $150/28-day supply). This card is not available to Horizon Medicare Blue or NJ FamilyCare Medicaid enrollees.
Options if Horizon Blue Cross Blue Shield of New Jersey won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide tablet approved for type 2 diabetes. Covered for T2D with PA on most plans; also subject to the IRA Maximum Fair Price of $274/30-day for Medicare patients effective January 1, 2027. Verify tier on Horizon's drug lookup.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as oral step therapy before or alongside Ozempic PA. Often available at a lower cost-share tier. NJ FamilyCare covers SGLT-2 inhibitors for T2D.
Wegovy (semaglutide 2.4 mg)
On-label for weight management. Horizon's commercial Wegovy coverage is plan-dependent — it may cover for weight management with PA (BMI criteria and prior weight-loss attempt documentation), but this is a separate PA pathway from Ozempic's T2D coverage. Confirm Wegovy weight-loss coverage with your specific Horizon plan separately.
Compounded semaglutide (weight-loss seekers only)
For patients seeking semaglutide for weight management who are denied under Horizon, compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Horizon BCBS of NJ does not cover Ozempic for weight loss under any line of business. Ozempic is FDA-approved for type 2 diabetes and cardiovascular risk reduction in T2D patients with known heart disease — not for weight management. Off-label weight-loss use is not a covered medical necessity under any Horizon plan. If weight management is the goal, Wegovy is the on-label option; Horizon's commercial Wegovy coverage is plan-dependent and requires separate PA with BMI and prior-attempt documentation.
Yes. Horizon BCBS of NJ covers Ozempic for type 2 diabetes with prior authorization based on medical necessity across commercial, ACA, Horizon Medicare Blue, and NJ FamilyCare Medicaid lines. PA requires a documented T2D diagnosis and evidence of prior oral antidiabetic therapy. Formulary tier and copay are not publicly confirmed at the drug level — verify on Horizon's drug lookup or by calling Horizon member services for your specific plan.
Horizon covers Ozempic for type 2 diabetes through a standard medical necessity PA process. Wegovy for weight management at Horizon is plan-dependent and involves additional PA criteria — BMI documentation, prior weight-loss attempt history, and ongoing monitoring requirements. The two drugs serve different FDA-approved indications and are handled under separate PA pathways at Horizon. Never assume Ozempic T2D coverage implies Wegovy weight-loss coverage, or vice versa.
Yes. NJ FamilyCare (New Jersey Medicaid) covers Ozempic for type 2 diabetes with prior authorization and nominal Medicaid cost-share. Horizon manages some NJ FamilyCare managed-care plans. If you have NJ FamilyCare, your specific coverage terms — including tier and copay — depend on whether you are enrolled in Horizon's NJ FamilyCare plan or another NJ Medicaid MCO (Aetna Better Health NJ, Wellcare NJ, etc.). Contact your NJ FamilyCare managed-care plan directly to confirm.
Yes, if you have a Horizon BCBS NJ commercial or employer-sponsored plan and a confirmed T2D diagnosis. The NovoCare Ozempic Savings Card may reduce your cost to as little as $25 per fill (max $150/28-day supply). The card is not available to Horizon Medicare Blue or NJ FamilyCare enrollees — federal anti-kickback rules exclude government program beneficiaries. Verify current eligibility at NovoCare.com before assuming the card applies.
Related Articles
Does Horizon BCBS of New Jersey Cover Mounjaro? 2026 | Curex
Horizon BCBS of NJ covers Mounjaro for T2D with prior auth — not weight loss. NJ Medicaid's weight-loss GLP-1 coverage applies to Zepbound, not Mounjaro.
Read moreDoes BCBS Michigan Cover Contrave? 2026 MI Guide | Curex
BCBS Michigan upheld weight-loss exclusions (DIFS 2025). Contrave is plan-dependent. MI Medicaid favors weight-loss GLP-1s; Contrave varies by PDL.
Read moreDoes BCBS of Illinois Cover Jardiance? 2026
BCBS of Illinois (HCSC) covers Jardiance across commercial, ACA, Medicare, and Medicaid. Metformin-first step is common. 2026 MFP $197 for Medicare.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Horizon BCBS New Jersey Cover Wegovy? 2026 | Curex
Horizon BCBS NJ may cover Wegovy with prior authorization (BMI 30+ or 27+ with comorbidity), but coverage is plan-dependent. Verify on Horizon's formulary.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
Horizon BCBS of New Jersey does not cover Ozempic for weight loss. For New Jersey patients seeking semaglutide for weight management, Curex offers compounded semaglutide from $49/mo at getcurex.com/cl/glp — no Horizon prior authorization required, no insurance needed. Compounded tirzepatide is also available from $149/mo. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Horizon Blue Cross Blue Shield of New Jersey before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.